Last reviewed · How we verify

NCT06342063: BFRACL

The Effects of Preoperative Blood Flow Restriction Training in Patients Undergoing ACL Reconstruction

Completed NA Last updated 2 April 2024
What this trial tests

NA trial testing Blood Flow Restriction Therapy in ACL Injury in 32 participants. Completed in 31 January 2024.

Timeline
1 April 2021
Primary endpoint
31 October 2023
31 January 2024

Quick facts

Lead sponsorWomen's College Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment32
Start date1 April 2021
Primary completion31 October 2023
Estimated completion31 January 2024
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Women's College Hospital

Who can join

Adults 18 to 50, any sex, with ACL Injury or Sports Physical Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective feasibility study is designed to assess pre-operative BFR in patients awaiting ACL reconstruction. This study will serve the following: (1) to determine if BFR improves strength testing prior to surgery and (2) to determine if BFR reduces QF muscle group atrophy prior to surgery. Additionally, preliminary results on pre-operative clinical and quality of life scores will be collected. If this study shows encouraging results, it will serve as a template for a more comprehensive randomized control trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood Flow Restriction Therapy

Trials testing the same drug.

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

Other Women's College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06342063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing